Skip to content
Pharma Observatory a Scientist.com platform

Organization (Hospital)

Hospital de Base

ClinicalTrials.gov lists Hospital de Base as lead sponsor of 25 trials. It has 15 approved assets.

BR Hospital
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

5 0 2002 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Hospital de Base: 25 lead-sponsored trials and 2 legal-entity registrations.

Get the Hospital de Base report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (27)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 6
Acute Kidney Injury 5
Hypertension 5
Postoperative Pain 5
Hypotension 2

Showing 5 of 27 disease areas.

Start your 14-day trial Email me all 27 disease areas as a PDF

Trials by start year as sponsor or collaborator (19)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 3
2025 1
2024 1
2023 2
2022 1
2021 2
2020 1
2019 5
2018 2
2016 1

Showing 10 of 19 years.

Start your 14-day trial Email me all 19 years as a PDF

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (15)

Shown in this order: max phase first.

Approved assets
Drug Trials
Lidocaine 3
Esmolol 2
Infusion 1
Prophylactic ondansetron 1
sevoflurane and fentanil 1

Showing 5 of 15 approved assets.

Start your 14-day trial Email me all 15 approved assets as a PDF

Journals published in (50)

Shown in this order: most published in first.

Journals published in
Journal Publications
Hypertension (Dallas, Tex. : 1979) 11
Journal of hypertension 7
Arquivos brasileiros de cardiologia 3
Circulation 3
Journal of the American College of Cardiology 3

Showing 5 of 50 journals.

Start your 14-day trial Email me all 50 journals as a PDF

Organization relationships (2)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Aline Fusco Fares, MD Co sponsors trial with 1
Sao Jose do Rio Preto Medical School Co sponsors trial with 1

Latest dated events (33)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-04-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 33 events.

Start your 14-day trial Email me all 33 events as a PDF

Biomarker capability evidence (10)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ALK Trial collaborator Named in trial inclusion criteria
CSF2 Trial collaborator Named in trial inclusion criteria
CSF3 Trial collaborator Named in trial inclusion criteria
EGFR Trial collaborator Named in trial inclusion criteria
ROS1 Trial collaborator Named in trial inclusion criteria

Showing 5 of 10 evidence rows.

Start your 14-day trial Email me all 10 evidence rows as a PDF

Biomarkers this organization publishes on (9)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
SLC5A2 4
C5 1
C5AR1 1
EGFR 1
EPO 1

Showing 5 of 9 biomarkers.

Start your 14-day trial Email me all 9 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.